Business

Mark Cuban’s kind gesture after $1,000 drug bill

By Sohail Khan 16 August 2026, 5:19 pm

Benchmarks
Nifty24,366.00-29.85

FEATURED FUNDS★★★★★

Motilal Oswal Midcap Fund Direct-Growth

5Y Return
23.43 %

Invest Now

Enter search text:

Business News›News›International›Global Trends›Mark Cuban’s ‘beyond incredible’ gesture wins hearts after heart transplant survivor faces $1,000 bill for vital medicine

Read Today's Paper

Mark Cuban’s ‘beyond incredible’ gesture wins hearts after heart transplant survivor faces $1,000 bill for vital medicine

Synopsis

After undergoing a heart transplant, a survivor encountered steep increases in medication costs, initially losing her insurance coverage only for it to be reinstated at a premium rate of $1,000. Her story spead on social media and in a generous move, billionaire Mark Cuban's pharmacy stepped in to provide the necessary medication at a lower price, with a supportive nonprofit now stepping forward to handle the patient’s medication costs.

Mark Cuban’s ‘beyond incredible’ gesture wins hearts after heart transplant survivor faces $1,000 bill for vital medicine<br> — Mark Cuban’s pharmacy eventually stepped in to supply Herres with the medication

A heart transplant survivor’s struggle to get affordable access to a critical anti-rejection medication has drawn attention online. The incident also prompted billionaire entrepreneur Mark Cuban to step in after her insurance coverage became too expensive to cover.

ALSO READ: World’s 2nd-richest country to give 2.4 million citizens up to S$600 in September 2026 as cost-of-living support: Check who qualifies

Heart transplant survivor faced a steep drug bill

Payton Herres, 26, underwent a heart transplant when she was a preteen. About a year after the surgery, she began taking everolimus, a generic version of Novartis’ anti-rejection drug Zortress, off-label.

Herres had been paying about $180 for a 90-day supply of the medication. But last year, her insurance provider, Elevance Health, told her it would no longer cover the drug.

With few options left, Herres shared her experience on Facebook. “I didn't know what else to do,” she told MarketWatch.

ALSO READ: Quote of the day by Naomi Campbell: "Anger is a manifestation of a deeper issue… and that, for me, is based on…"

Her post was shared thousands of times. A day after she posted about her situation, her insurance coverage was restored. However, the price she was required to pay had changed dramatically.

Instead of $180 for a 90-day supply, Herres was faced with a $1,000 bill. “I call that ghost approval. Technically, you approved it,” Herres told MarketWatch. “But I still can't realistically get the med because you [made] it financially impossible to get.”

Her story went viral again

Herres’ situation gained renewed attention after The Independent published a story about Mary Cutter, whose 24-year-old son died in 2012. Cutter’s son was an organ donor, and his heart was ultimately transplanted into Herres.

After learning about Herres’ struggle to afford the medication, Cutter offered to pay for the drug so that Herres could continue taking it.

The story was subsequently shared on social media, where Warris Bokhari, CEO and co-founder of Claimable, and billionaire entrepreneur Mark Cuban were tagged.

Cuban reacted strongly to Herres’ situation on LinkedIn. “This is beyond incredible,” Cuban wrote. He added: “Approve and pay for the heart transplant. Deny the generic rejection medicine.”

Mark Cuban’s pharmacy helped lower the cost

Cuban’s pharmacy eventually stepped in to supply Herres with the medication. She is now able to obtain the drug for about $300 for a 90-day supply, according to the report. A nonprofit connected with Bokhari’s startup is covering the costs.

The intervention means Herres will no longer have to pay $1,000 price that followed the restoration of her insurance coverage.

Health insurance denials are affecting more Americans

Herres’ experience comes as patients across the United States continue to report difficulties getting medical care and prescription medicines covered by insurance.

A recent IQVIA study found that 70% of commercially insured patients were initially denied coverage for at least one newly prescribed branded medicine in 2024. Nearly one in four patients were still unable to obtain approval for any new prescriptions after a year.

Insurance disputes are not limited to prescription drugs.

A Commonwealth Fund survey found that 21% of working-age adults with private insurance said they or a family member had experienced a denial for medical care recommended by a doctor. Among those who experienced a denial, nearly 70% said the denial resulted in additional costs for their household.

Add as a Reliable and Trusted News Source
Add Now!

(You can now subscribe to our WhatsApp channel)

(You can now subscribe to our WhatsApp channel)

Read More News on
Mark CubanPayton Herresheart transplant survivorhealth insurance denialeverolimusElevance Healthprescription drug costsinsurance claim deniedhealthcare costsheart transplant medicine

Enter search text:

Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories

& personalised newsletters
Login Now

Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions &

in-depth stock reports
Subscribe Now

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Subscribe to gain powerful insights on business, stock market and industry trends.

Big Price Drop! Flat 40% Off

Student Only Offer

Already a Member? Sign In now

Already a Member? Sign In now
Already a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail Offer
Avail Offer

Claim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004

' + h3 + '

' + h4 + '

' + listing + '

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with in-depth insights that matter

Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

The problem with lab grown diamonds
Why a falling rupee is a better option for the economy

A list of top 20 momentum stocks that have delivered massive returns in one year